Leptin analogs and MC4R agonists are exclusively used for patients with obesity secondary to congenital/acquired generalized lipodystrophy and POMC deficiency, respectively. The gene discussed is POMC; the disease is hyperinsulinemic hypoglycemia, familial, 4.